期刊文献+

原发性与继发性肾小球病患者24小时动态血压特点对比分析 被引量:3

Comparison analysis of 24 h ambulatory blood pressure monitoring between primary and secondary glomerular disease
下载PDF
导出
摘要 目的探讨原发性肾小球病与继发性肾小球病患者24 h动态血压的差异,以指导临床个体化降压治疗。方法选择原发性肾小球病患者64例,均未行肾脏替代治疗,并随机选择与其年龄、性别、估测肾小球滤过率(eGFR)相匹配的继发性肾小球病患者57例,两组患者均行24 h动态血压监测。结果①继发性肾小球病组24 h平均收缩压、夜间平均收缩压和夜间收缩压负荷高于原发性肾小球病组,差异有统计学意义(P<0.05)。②两组患者血压变异性和晨峰血压差异无统计学意义(P>0.05)。③原发性肾小球病组39.0%为勺型血压,43.8%为非勺型血压,17.2%为反勺型血压;继发性肾小球病组10.5%为勺型血压,47.4%为非勺型血压,42.1%为反勺型血压;原发性肾小球病组异常血压类型比例为61.0%,继发性肾小球病组异常血压类型比例为89.5%,差异有统计学意义(P<0.05)。结论继发性肾小球病患者夜间收缩压控制较原发性肾小球病患者差,前者异常血压更顽固。建议针对继发性肾小球病患者夜间血压采取个体化治疗,有针对性地调整降压方案。 Objective To investigate the characteristics of 24 h ambulatory blood pressure monitoring of primary and secondary glomerular disease so as to guide the individual antihypertensive treatment in clinics. Methods Sixty-four patients with primary glomerular disease were selected, more of them not undergone renal replacement treatment. Besides, 57 patients with secondary glomerular disease matched with age, gender and estimated glomerular filtration rate (eGFR) were randomly selected. Twenty-four hour ambulatory blood pressure monitoring was carried out in both groups. Results (1)The 24 h mean systolic blood pressure, night mean systolic blood pressure and night systolic load in secondary glomerular disease group were significantly higher than those in primary glomerular disease group ( P 〈 0.05) . (2) There was no significant difference in blood pressure variability and morning surge between two groups (P 〉 0.05). (3) In primary glomerular disease group, dipper blood pressure accounted for 39.0%, non-dipper blood pressure 43.8% and anti-dipper blood pressure 17.2%. In secondary glomerular disease group, dipper blood pressure accounted for 10.5%, non-dipper blood pressure 47.4% and anti-dipper blood pressure 42.1%. There were significant differences in the percentage of abnormal blood pressure between primary glomerular disease group and secondary glomerular disease group (61.0% vs 89.5%, P 〈 0.05). Conclusion The control of night systolic blood pressure in patients with secondary glomerular disease is poorer than that in patients with primary glomerular disease, and abnormal blood pressure in secondary glomerular disease is much more resistant. It is advised to individualize the antihypertensive treatment of night systolic blood pressure in patients with secondary glomerular disease.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第4期463-467,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 湖南省自然科学基金(10JJ5029) 国家科技支撑计划(2012BAI37B05) 重大基础研究前期研究专项基金(2011CB512001) 肾功能损害合并高血压患者优化降压方案的研究(81273594)~~
关键词 原发性肾小球病 继发性肾小球病 动态血压监测 primary chronic glomerular disease secondary chronic glomerular disease ambulatory blood pressure monitoring
  • 相关文献

参考文献18

  • 1中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616. 被引量:4512
  • 2林静,丁小强,吉俊,傅辰生,钟一红,邹建州,滕杰,方艺.慢性肾脏病患者高血压现状的横断面调查[J].中华肾脏病杂志,2009,25(11):827-831. 被引量:34
  • 3Mojon A, Ayala DE, Pineiro L, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease[J]. Chronobiol Int, 2013, 30 ( 1 - 2) : 145 - 158.
  • 4Fukuda M, Munemura M, Usami T, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deterio- rates in nephropathy [ J ]. Kidney Int, 2004, 65 (2) : 621 - 625.
  • 5Tseng YZ. Applications of 24-hour noninvasive ambulatory blood pressure monitoring[ J]. J Formos Med Assoc, 2006, 105 (12) : 955 -963.
  • 6Wen KC, Gourishankar S. Evaluating the utility of ambulatory blood pressure monitoring in kidney transplant recipients[ J]. Clin Transplant, 2012, 26 (5) : E465 - 470.
  • 7段留法,郑秋甫.收缩压、舒张压和脉压对预测心血管疾病危险的临床评价[J].解放军保健医学杂志,2004,6(2):118-120. 被引量:11
  • 8Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximmn systolic blood pressure, and episodic hypertension [ J ]. Lancet, 2010, 375 (9718 ) : 895 - 905.
  • 9张维忠.血压变异和晨峰的概念及其临床意义[J].中华心血管病杂志,2006,34(3):287-288. 被引量:300
  • 10Kario K. Morning surge and variability in blood pressure: a new therapeutic target? [ J ] Hypertension, 2005, 45 (9) : 485 - 486.

二级参考文献48

  • 1张维忠.血压变异和晨峰的概念及其临床意义[J].中华心血管病杂志,2006,34(3):287-288. 被引量:300
  • 2猿田享男,任常陵.日本高血压学会高血压治疗指南及其特征(2004年修订版)[J].日本医学介绍,2006,27(5):198-200. 被引量:2
  • 3Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-200,4. Hypertension, 2007, 49: 69-75.
  • 4Centers for Disease Control and Prevention(CDC). Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004. MMWR Morb Mortal Wkly Rep, 2007, 56: 161-165.
  • 5Sarafidis PA, Ei S, Chen SC, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med, 2008, 121: 332-340.
  • 6Jafar TH, Schmid CH, Landa M, et al. Angiotensinconverting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med, 2001, 135: 73-87.
  • 7K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis, 2004, 43(5 Suppl 1): S1-S290.
  • 8Lenfant C, Chobanian AV, Jones DW, et al. Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension, 2003, 41: 1178-1179.
  • 9Whitworth JA. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens, 2003, 21: 1983- 1992.
  • 10Churg J BJ, Glassock RJ. Renal disease: classification and atlas of glomerular diseases. 2nd ed. Tokyo: lgaku-Shoin, 1995: 1-225.

共引文献4853

同被引文献22

  • 1张碧丽,韩鸿玲,宋兰云,张暄,杜悦新,王文红.儿童原发性肾小球疾病病理积分与临床参数关系的研究[J].天津医药,2006,34(9):613-615. 被引量:1
  • 2Bangash F, Agarwal R. Masked hypertension and white-coat hyper- tension in chronic kidney disease: a Meta-analysis [ J ]. Clin J Am Soc Nephrol, 2009, 4(3): 656-664.
  • 3LeeAnn Braun, Vipan Sood, Susan Hogue, et al. High burden and unmet patient needs in chronic kidney disease [ J ]. Int J Nephrol Renovasc Dis, 2012, 5: 151-163.
  • 4Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[ J]. Lancet, 2012, 379 (9818) : 815-822.
  • 5Collins AJ, Foley RN, Chavers B, et al. USRDS 2010 Annum Data Report: atlas of chronic kidney disease and end-stage renal disease in the united states, national institutes of health, national institute of diabetes and digestive and kidney diseases [ J ]. Am J Kidney Dis, 2012, 59(1 Suppl 1) : A7, e1-420.
  • 6Sarafidis PA, Li S, Chen SC, et al. Hypertension awareness, treat- ment, and control in chronic kidney disease [ J]. Am J Med, 2008, 121(4) : 332-340.
  • 7Heerspink HJ, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised con- trolled trials[Jl. Lancet, 2009, 373(9668) : 1 009-015.
  • 8Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey[J]. Am J Kidney Dis, 2003, 41 ( 1 ) : 1-12.
  • 9Sumaili EK, Cohen EP, Zinga CV, et al. High prevalence of undi- agnosed chronic kidney disease amongm-fisk population in Kinsha- sa, the Democratic Republic of Congo[J]. BMC Nephrol, 2009, 21(10): 18.
  • 10Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambu- latory blood pressure monitoring versus screening blood pressure ts: a pilot study in Ohasama [J]. J Hypertens, 1997, 15(4): 357-364.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部